Thursday, August 31, 2023 6:33:36 PM
Which Industry Players Will Benefit?
by
Nicolás Jose Rodriguez, Benzinga Staff Writer
August 31, 2023 4:34 PM | 2 min read
The Department of Health and Human Services' recommendation to reclassify marijuana as a Schedule III drug under the Controlled Substances Act set off ripples across the cannabis market.
One day following Wednesday's news, MSOS ETF
MSOS
surged by 21%. Notable companies also experienced remarkable gains, with State House Holdings Inc.
STHZF
skyrocketing by 74%, Columbia Care
CCHWF
witnessing a 38% boost, Jushi
JUSH
rising by 32%, and Ayr Wellness
AYRWF
showing a 29% increase.
This proposal holds crucial implications for taxation and cannabis businesses, particularly regarding Section 280E.
According to analysis firm Zuanic & Associates (Z&A) the removal of 280E, irrespective of federal legalization, stands to significantly bolster company cash flows.
Cannabis Companies Primed For Cash Flow Surge
Pablo Zuanic, chief analyst at Z&A noted that current calculations show companies with positive operating cash flow and profit before tax could reduce their income tax rates to 70% of PBT, as opposed to the standard 21% rate sans 280E.
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM